Prescribing of two potentially interacting cardiovascular medications in atrial fibrillation patients on direct oral anticoagulants

BACKGROUND: Amiodarone and diltiazem are commonly recommended cardiovascular medications for use in atrial fibrillation (AF) patients. They are known to have drug-drug interactions (DDIs) with direct oral anticoagulants (DOACs). We aimed to evaluate frequency of use of amiodarone or diltiazem among...

Descripción completa

Detalles Bibliográficos
Autores principales: Shurrab, Mohammed, Koh, Maria, Jackevicius, Cynthia A., Qiu, Feng, Conlon, Michael, Caswell, Joseph, Tu, Karen, Austin, Peter C., Ko, Dennis T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105295/
https://www.ncbi.nlm.nih.gov/pubmed/33997261
http://dx.doi.org/10.1016/j.ijcha.2021.100788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105295/
https://www.ncbi.nlm.nih.gov/pubmed/33997261
http://dx.doi.org/10.1016/j.ijcha.2021.100788

Ejemplares similares